Internationalization,
a way of thinking

Fidia farmaceutici S.p.A. is an Italian company with firm foundations in its home market, but its long tradition of products and investment in research has given it international appeal.

Today, Fidia is expanding its global reach and successfully distributes its products worldwide, through an established network of international partners operating in the pharmaceutical and biomedical sectors, both on a global and local scale. As a result of a long-standing belief in the value of research and a wise choice of partnerships, Fidia has some considerable achievements to its name.

One example is in the sector of intra-articular joint therapy, in which it is European leader and a key player in the United States with its hyaluronic acid-based products for the treatment of osteoarthritis. As a result, more than 14,000 patients have been involved so far in 110+ clinical trials worldwide, with over 50 million injections administered since launch in 1987.

Fidia's pipeline of products comprises medicinal products, medical devices and nutritional supplements.

The international approach is crucial to the company, whose products are present in over 100 countries worldwide, through a comprehensive network of alliances and distributors, among which are major players in the pharmaceutical market segments in which Fidia operates.

The pharmaceutical segment is extremely crowded, thus optimizing performance in the pharmerging sector will be increasingly important for the company's global success and sustainable competitive edge. Since attractive market dynamics usually mean new market opportunities, Fidia is establishing a direct presence in attractive markets - including the US and Germany - with local business and liaison offices.
 

Over 100 markets worldwide: Europe, North America, Latin America, Middle East, and Far East.

Almost 60% of sales are achieved internationally.

Key products in our portfolio: HYALGAN® (HYALART®), HYALUBRIX®, HYALONE®, HYMOVIS®, ITAMI®, HYALO4®.

Health
Products
Website

Find out more about Fidia’s product portfolio:

Go to the website

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint healthcare
- wound care
- dermatology
- neurology
- dermo-aesthetics
- ophthalmology